Chimera Investment Corporation (NYSE:CIM) has reported its financial results for the fourth quarter and full year ending December 31, 2024. The company announced a GAAP net loss of $2.04 per diluted common share for the fourth quarter of 2024, compared to a GAAP net income of $1.10 per diluted common share for the full year 2024. Similarly, earnings available for distribution per diluted common share stood at $0.37 for the fourth quarter, while it was $1.48 for the full year.
The company's GAAP book value per common share at December 31, 2024, was $19.72, reflecting an economic return of 4.40% for the year ended December 31, 2024.
In terms of the company's financial condition, it reported a decrease in cash and cash equivalents from $221,684 in December 31, 2023, to $83,998 in December 31, 2024. Additionally, the fair value of non-agency RMBS and agency MBS increased from $1,043,806 and $102,484, respectively, in December 31, 2023, to $1,064,169 and $519,218, respectively, in December 31, 2024. However, the fair value of loans held for investment decreased from $11,397,046 in December 31, 2023, to $11,196,678 in December 31, 2024.
Looking at the net income for the years ended December 31, 2024, and 2023, it increased from $126,104 in 2023 to $176,065 in 2024. The company reported net income (loss) available to common shareholders of $90,329 for 2024, compared to $52,354 for 2023. The weighted average number of common shares outstanding also increased from 76,685,785 in 2023 to 80,976,745 in 2024.
Earnings available for distribution, a non-GAAP measure, stood at $30,448 for the fourth quarter of 2024, showing consistent performance throughout the year with figures of $29,866, $30,308, and $30,564 in the previous quarters. These figures were slightly lower than the $30,735 reported in the fourth quarter of 2023.
In terms of the MBS portfolio, at December 31, 2024, the weighted average fair value of non-agency RMBS increased to $60.83 from $45.11, and the weighted average fair value of agency RMBS increased to $99.36 from $99.97, as compared to December 31, 2023.
Following these announcements, the company's shares moved -7.8%, and are now trading at a price of $13.92. For the full picture, make sure to review Chimera Investment's 8-K report.